Free tool
Diagnostics stocks
We cover 46 companies grouped under the Diagnostics theme. The median market value in the group is $320.87M. Across the group, the median move over the past trading day is +0.30%. 44% of the 45 with a 200-day average trade above it. Price change over the past year runs from −57.6% to +79.3% across the middle 80 percent of the group, with a median of −9.6%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
46 of 150 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| PSNL | Personalis, Inc. | $17.25 | +43.99% | +119.75% | +267.02% |
| DIA.WA | Diagnostyka S.A. | 166.50 PLN | +0.54% | −3.70% | −17.53% |
| 4544.T | H.U. Group Holdings, Inc. | 3,678.00 JPY | +5.93% | +9.61% | +11.45% |
| OPK | OPKO Health, Inc. | $1.49 | +20.16% | +17.32% | +7.19% |
| QDEL | QuidelOrtho Corporation | $15.05 | −10.58% | −47.71% | −45.57% |
| CSTL | Castle Biosciences, Inc. | $35.00 | +43.21% | −9.19% | +70.15% |
| 4694.T | BML, Inc. | 3,670.00 JPY | +1.66% | −2.27% | +7.64% |
| IDX.AX | Integral Diagnostics Limited | 2.40 AUD | +15.38% | −3.07% | −17.78% |
| DASA3.SA | Diagnósticos da América S.A. | 2.62 BRL | −8.07% | −41.52% | +111.29% |
| FLGT | Fulgent Genetics, Inc. | $19.95 | +1.89% | −22.04% | −7.34% |
| 137310.KS | SD Biosensor, Inc. | 6,260.00 KRW | +2.45% | −29.32% | −36.08% |
| 4549.T | Eiken Chemical Co., Ltd. | 2,349.00 JPY | −4.59% | −1.31% | −2.85% |
| CEVI.ST | CellaVision AB (publ) | 167.40 SEK | +15.93% | +13.18% | −3.32% |
| ACL.AX | Australian Clinical Labs Limited | 2.89 AUD | +20.42% | +7.73% | +12.06% |
| VOX.WA | Voxel S.A. | 130.40 PLN | +2.68% | +7.24% | −20.15% |
| NIOX.L | NIOX Group Plc | 68.00 GBP | +11.48% | +0.03% | −6.05% |
| 0K3W.L | Myriad Genetics, Inc. | $3.15 | +2.95% | −49.12% | −46.71% |
| N3B.F | Anbio Biotechnology | 5.50 EUR | −36.78% | −67.46% | −86.59% |
| NNNN | Anbio Biotechnology | $7.83 | −23.08% | −73.44% | −84.06% |
| 0KCC.L | Insight Molecular Diagnostics Inc. | $4.42 | +2.67% | −36.40% | +80.26% |
| 197A.T | TAUNS LABORATORIES INC. | 503.00 JPY | +6.34% | −0.79% | −11.01% |
| YDES | YD Bio Ltd | $4.68 | +104.37% | −61.00% | −64.97% |
| SBS.DE | Stratec SE | 22.35 EUR | +7.97% | +1.13% | −16.29% |
| IDHC.L | Integrated Diagnostics Holdings plc | $0.55 | −0.73% | −21.91% | +20.85% |
| BDSX | Biodesix, Inc. | $28.08 | +26.35% | +334.60% | +186.48% |
| MYGN | Myriad Genetics, Inc. | $3.19 | −41.47% | −48.05% | −45.84% |
| 0RAR.L | Stratec SE | 23.05 EUR | +2.67% | +4.06% | −13.37% |
| OSUR | OraSure Technologies, Inc. | $3.78 | −4.55% | +58.82% | +20.38% |
| ALERS.PA | Eurobio Scientific Société anonyme | 20.50 EUR | −3.76% | −15.11% | −18.97% |
| HLS.AX | Healius Limited | 0.43 AUD | +23.43% | −52.53% | −55.00% |
| 4595.T | Mizuho Medy Co.,Ltd. | 1,732.00 JPY | +3.34% | +0.06% | +13.41% |
| LUCD | Lucid Diagnostics Inc. | $1.01 | +11.85% | −9.82% | −12.93% |
| XGN | Exagen Inc. | $7.60 | +72.73% | +25.83% | −22.84% |
| PEB.AX | Pacific Edge Limited | 0.21 AUD | −6.82% | +28.12% | +64.00% |
| 4671.T | FALCO HOLDINGS Co., Ltd. | 2,862.00 JPY | +5.84% | +8.96% | +21.25% |
| S2B.WA | Syn2bio S.A. | 64.90 PLN | −5.94% | +81.79% | +81.79% |
| 0ELV.L | Guerbet SA | 7.88 EUR | −0.63% | −47.47% | −62.12% |
| IMDX | Insight Molecular Diagnostics Inc. | $4.44 | −5.53% | −37.99% | +78.31% |
| EKF.L | EKF Diagnostics Holdings plc | 25.40 GBP | −3.42% | −4.33% | −13.90% |
| BVXP.L | Bioventix PLC | 1,750.00 GBP | +15.89% | −5.88% | −30.64% |
| PCSC | Perceptive Capital Solutions Corp | $11.95 | +0.67% | −8.08% | +13.16% |
| SCP.WA | Scope Fluidics S.A. | 139.80 PLN | +19.28% | 0.00% | −9.34% |
| S84.F | Scope Fluidics S.A. | 27.75 EUR | +19.87% | −25.90% | −9.76% |
| QUCY | Quantum Cyber N.V. | $1.36 | +23.64% | +17.24% | −20.93% |
| BNR | Burning Rock Biotech Limited | $9.80 | +4.26% | −50.20% | +13.95% |
| DVYSR.ST | Devyser Diagnostics AB (publ) | 59.60 SEK | −12.61% | −47.54% | −60.27% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.